170 related articles for article (PubMed ID: 23890084)
1. Differences in microRNA expression during tumor development in the transition and peripheral zones of the prostate.
Carlsson J; Helenius G; Karlsson MG; Andrén O; Klinga-Levan K; Olsson B
BMC Cancer; 2013 Jul; 13():362. PubMed ID: 23890084
[TBL] [Abstract][Full Text] [Related]
2. Cellular density of low-grade transition zone prostate cancer: A limiting factor to correlate restricted diffusion with tumor aggressiveness.
Barral M; Jemal-Turki A; Beuvon F; Soyer P; Camparo P; Cornud F
Eur J Radiol; 2020 Oct; 131():109230. PubMed ID: 32866908
[TBL] [Abstract][Full Text] [Related]
3. Genes differentially expressed in the peripheral zone compared to the transitional zone of the normal human prostate and their potential regulation by ETS factors.
Adler D; Lindstrot A; Ellinger J; Rogenhofer S; Buettner R; Wernert N
Mol Med Rep; 2012 Jan; 5(1):32-6. PubMed ID: 21993862
[TBL] [Abstract][Full Text] [Related]
4. Tumor formation of prostate cancer cells influenced by stromal cells from the transitional or peripheral zones of the normal prostate.
Zhao FJ; Han BM; Yu SQ; Xia SJ
Asian J Androl; 2009 Mar; 11(2):176-82. PubMed ID: 19122679
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of the human prostate zones.
van der Heul-Nieuwenhuijsen L; Hendriksen PJ; van der Kwast TH; Jenster G
BJU Int; 2006 Oct; 98(4):886-97. PubMed ID: 16978289
[TBL] [Abstract][Full Text] [Related]
6. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
Zhao H; Ramos CF; Brooks JD; Peehl DM
J Cell Physiol; 2007 Jan; 210(1):111-21. PubMed ID: 17044071
[TBL] [Abstract][Full Text] [Related]
7. Single-cell RNA sequencing of human prostate basal epithelial cells reveals zone-specific cellular populations and gene expression signatures.
Vellky JE; Wu Y; Moline D; Drnevich J; Maienschein-Cline M; Valyi-Nagy K; Kajdacsy-Balla A; Vander Griend DJ
J Pathol; 2024 Feb; 262(2):212-225. PubMed ID: 37984408
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the biological features between prostate cancers arising in the transition and peripheral zones.
Sakai I; Harada K; Hara I; Eto H; Miyake H
BJU Int; 2005 Sep; 96(4):528-32. PubMed ID: 16104904
[TBL] [Abstract][Full Text] [Related]
9. The peripheral zone of the prostate is more prone to tumor development than the transitional zone: is the ETS family the key?
Adler D; Lindstrot A; Ellinger J; Rogenhofer S; Buettner R; Perner S; Wernert N
Mol Med Rep; 2012 Feb; 5(2):313-6. PubMed ID: 22038307
[TBL] [Abstract][Full Text] [Related]
10. Molecular differences in transition zone and peripheral zone prostate tumors.
Sinnott JA; Rider JR; Carlsson J; Gerke T; Tyekucheva S; Penney KL; Sesso HD; Loda M; Fall K; Stampfer MJ; Mucci LA; Pawitan Y; Andersson SO; Andrén O
Carcinogenesis; 2015 Jun; 36(6):632-8. PubMed ID: 25870172
[TBL] [Abstract][Full Text] [Related]
11. Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones.
Sakai I; Harada K; Kurahashi T; Yamanaka K; Hara I; Miyake H
Int J Urol; 2006 Apr; 13(4):368-72. PubMed ID: 16734852
[TBL] [Abstract][Full Text] [Related]
12. Elevation of dipeptidylpeptidase iv activities in the prostate peripheral zone and prostatic secretions of men with prostate cancer: possible prostate cancer disease marker.
Wilson MJ; Haller R; Li SY; Slaton JW; Sinha AA; Wasserman NF
J Urol; 2005 Sep; 174(3):1124-8. PubMed ID: 16094078
[TBL] [Abstract][Full Text] [Related]
13. Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumours located in the transition zone and in the peripheral zone.
Erbersdobler A; Fritz H; Schnöger S; Graefen M; Hammerer P; Huland H; Henke RP
Eur Urol; 2002 Jan; 41(1):40-6. PubMed ID: 11999464
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
[TBL] [Abstract][Full Text] [Related]
15. Molecular disorders in transitional vs. peripheral zone prostate adenocarcinoma.
Colombo P; Patriarca C; Alfano RM; Cassani B; Ceva Grimaldi G; Roncalli M; Bosari S; Coggi G; Campo B; Gould VE
Int J Cancer; 2001 Nov; 94(3):383-9. PubMed ID: 11745418
[TBL] [Abstract][Full Text] [Related]
16. Effects of age, sex steroids, and family relationships on volumes of prostate zones in men with and without prostate cancer.
Meikle AW; Stephenson RA; McWhorter WP; Skolnick MH; Middleton RG
Prostate; 1995 May; 26(5):253-9. PubMed ID: 7753710
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of zone-specific spectral signatures in normal human prostate using Raman spectroscopy.
Patel II; Martin FL
Analyst; 2010 Dec; 135(12):3060-9. PubMed ID: 20949203
[TBL] [Abstract][Full Text] [Related]
18. Do prostatic transition zone tumors have a distinct morphology?
Garcia JJ; Al-Ahmadie HA; Gopalan A; Tickoo SK; Scardino PT; Reuter VE; Fine SW
Am J Surg Pathol; 2008 Nov; 32(11):1709-14. PubMed ID: 18769336
[TBL] [Abstract][Full Text] [Related]
19. Optimizing size thresholds for detection of clinically significant prostate cancer on MRI: Peripheral zone cancers are smaller and more predictable than transition zone tumors.
Mahjoub S; Baur ADJ; Lenk J; Lee CH; Hartenstein A; Rudolph MM; Cash H; Hamm B; Asbach P; Haas M; Penzkofer T
Eur J Radiol; 2020 Aug; 129():109071. PubMed ID: 32531720
[TBL] [Abstract][Full Text] [Related]
20. Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume.
Simpkin CJ; Morgan VA; Giles SL; Riches SF; Parker C; deSouza NM
Br J Radiol; 2013 Apr; 86(1024):20120469. PubMed ID: 23426849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
